Pheton (PTHL) Competitors

$0.35 0.00 (-0.48%)

As of 05/4/2026

PTHL vs. PAVM, TNON, SINT, NXL, and NVNO

Should you be buying Pheton stock or one of its competitors? The main competitors of Pheton include PAVmed (PAVM), Tenon Medical (TNON), Sintx Technologies (SINT), Nexalin Technology (NXL), and enVVeno Medical (NVNO). These companies are all part of the "medical equipment" industry.

How does Pheton compare to PAVmed?

Pheton (NASDAQ:PTHL) and PAVmed (NASDAQ:PAVM) are both small-cap medical companies, but which is the better stock? We will compare the two companies based on the strength of their risk, analyst recommendations, institutional ownership, media sentiment, valuation, dividends, earnings and profitability.

: PAVmed has a net margin of 564.79% compared to Pheton's net margin of 0.00%. Pheton's return on equity of 0.00% beat PAVmed's return on equity.
Company Net Margins Return on Equity Return on Assets
Pheton N/A N/A N/A
PAVmed 564.79% -242.99% -17.25%
: PAVmed has lower revenue, but higher earnings than Pheton.
Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio
Pheton $305.22K 7.57 -$660K N/A N/A
PAVmed $70K 115.00 $400K -$22.77 N/A
: Pheton has a beta of 5.4, meaning that its stock price is 440% more volatile than the S&P 500. Comparatively, PAVmed has a beta of 0.64, meaning that its stock price is 36% less volatile than the S&P 500.
: PAVmed has a consensus price target of $65.00, suggesting a potential upside of 707.45%. Given PAVmed's stronger consensus rating and higher possible upside, analysts clearly believe PAVmed is more favorable than Pheton.
Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Pheton
1 Sell rating(s)
0 Hold rating(s)

0 Buy rating(s)

0 Strong Buy rating(s)
1.00
PAVmed
1 Sell rating(s)

1 Hold rating(s)

1 Buy rating(s)

0 Strong Buy rating(s)
2.00
: In the previous week, PAVmed had 2 more articles in the media than Pheton. MarketBeat recorded 3 mentions for PAVmed and 1 mentions for Pheton. Pheton's average media sentiment score of 0.00 equaled PAVmed'saverage media sentiment score.
Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Pheton
0 Very Positive mention(s)
0 Positive mention(s)
1 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Neutral
PAVmed
0 Very Positive mention(s)
0 Positive mention(s)
3 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Neutral
: 19.9% of PAVmed shares are held by institutional investors. 5.8% of PAVmed shares are held by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company is poised for long-term growth.

Company	Net Margins	Return on Equity	Return on Assets
Pheton	N/A	N/A	N/A
PAVmed	564.79%	-242.99%	-17.25%

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Pheton	$305.22K	7.57	-$660K	N/A	N/A
PAVmed	$70K	115.00	$400K	-$22.77	N/A

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Pheton	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.00
PAVmed	1 Sell rating(s)	1 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	2.00

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Pheton	0 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral
PAVmed	0 Very Positive mention(s)	0 Positive mention(s)	3 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral

Summary

PAVmed beats Pheton on 9 of the 13 factors compared between the two stocks.

How does Pheton compare to Tenon Medical?

Pheton (NASDAQ:PTHL) and Tenon Medical (NASDAQ:TNON) are both small-cap medical companies, but which is the superior stock? We will compare the two companies based on the strength of their analyst recommendations, profitability, risk, valuation, institutional ownership, dividends, media sentiment and earnings.

: Pheton has a net margin of 0.00% compared to Tenon Medical's net margin of -318.36%. Pheton's return on equity of 0.00% beat Tenon Medical's return on equity.
Company Net Margins Return on Equity Return on Assets
Pheton N/A N/A N/A
Tenon Medical -318.36% -409.16% -110.06%
: Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Pheton
1 Sell rating(s)
0 Hold rating(s)

0 Buy rating(s)

0 Strong Buy rating(s)
1.00
Tenon Medical
1 Sell rating(s)

0 Hold rating(s)

1 Buy rating(s)

0 Strong Buy rating(s)
2.00
: 22.7% of Tenon Medical shares are owned by institutional investors. 0.3% of Tenon Medical shares are owned by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company will outperform the market over the long term.
: Pheton has a beta of 5.4, suggesting that its stock price is 440% more volatile than the S&P 500. Comparatively, Tenon Medical has a beta of 1.28, suggesting that its stock price is 28% more volatile than the S&P 500.
: Pheton has higher earnings, but lower revenue than Tenon Medical.
Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio
Pheton $305.22K 7.57 -$660K N/A N/A
Tenon Medical $3.94M 2.13 -$12.56M -$1.99 N/A
: In the previous week, Pheton and Pheton both had 1 articles in the media. Pheton's average media sentiment score of 0.00 equaled Tenon Medical'saverage media sentiment score.
Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Pheton
0 Very Positive mention(s)
0 Positive mention(s)
1 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Neutral
Tenon Medical
0 Very Positive mention(s)
0 Positive mention(s)
1 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Neutral

Company	Net Margins	Return on Equity	Return on Assets
Pheton	N/A	N/A	N/A
Tenon Medical	-318.36%	-409.16%	-110.06%

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Pheton	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.00
Tenon Medical	1 Sell rating(s)	0 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	2.00

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Pheton	$305.22K	7.57	-$660K	N/A	N/A
Tenon Medical	$3.94M	2.13	-$12.56M	-$1.99	N/A

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Pheton	0 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral
Tenon Medical	0 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral

Summary

Pheton beats Tenon Medical on 6 of the 11 factors compared between the two stocks.

How does Pheton compare to Sintx Technologies?

Pheton (NASDAQ:PTHL) and Sintx Technologies (NASDAQ:SINT) are both small-cap medical companies, but which is the better investment? We will contrast the two companies based on the strength of their earnings, media sentiment, risk, institutional ownership, dividends, profitability, valuation and analyst recommendations.

: Pheton has a net margin of 0.00% compared to Sintx Technologies' net margin of -1,018.08%. Pheton's return on equity of 0.00% beat Sintx Technologies' return on equity.
Company Net Margins Return on Equity Return on Assets
Pheton N/A N/A N/A
Sintx Technologies -1,018.08% -242.76% -99.86%
: Pheton has higher earnings, but lower revenue than Sintx Technologies.
Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio
Pheton $305.22K 7.57 -$660K N/A N/A
Sintx Technologies $1.02M 9.77 -$10.36M -$5.66 N/A
: 18.4% of Sintx Technologies shares are held by institutional investors. 4.1% of Sintx Technologies shares are held by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company is poised for long-term growth.
: Sintx Technologies has a consensus price target of $11.00, suggesting a potential upside of 354.55%. Given Sintx Technologies' stronger consensus rating and higher possible upside, analysts plainly believe Sintx Technologies is more favorable than Pheton.
Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Pheton
1 Sell rating(s)
0 Hold rating(s)

0 Buy rating(s)

0 Strong Buy rating(s)
1.00
Sintx Technologies
1 Sell rating(s)

0 Hold rating(s)

2 Buy rating(s)

0 Strong Buy rating(s)
2.33
: In the previous week, Pheton had 1 more articles in the media than Sintx Technologies. MarketBeat recorded 1 mentions for Pheton and 0 mentions for Sintx Technologies. Pheton's average media sentiment score of 0.00 equaled Sintx Technologies'average media sentiment score.
Company Overall Sentiment
Pheton Neutral
Sintx Technologies Neutral
: Pheton has a beta of 5.4, indicating that its stock price is 440% more volatile than the S&P 500. Comparatively, Sintx Technologies has a beta of 0.61, indicating that its stock price is 39% less volatile than the S&P 500.

Company	Net Margins	Return on Equity	Return on Assets
Pheton	N/A	N/A	N/A
Sintx Technologies	-1,018.08%	-242.76%	-99.86%

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Pheton	$305.22K	7.57	-$660K	N/A	N/A
Sintx Technologies	$1.02M	9.77	-$10.36M	-$5.66	N/A

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Pheton	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.00
Sintx Technologies	1 Sell rating(s)	0 Hold rating(s)	2 Buy rating(s)	0 Strong Buy rating(s)	2.33

Company	Overall Sentiment
Pheton	Neutral
Sintx Technologies	Neutral

Summary

Sintx Technologies beats Pheton on 7 of the 13 factors compared between the two stocks.

How does Pheton compare to Nexalin Technology?

Pheton (NASDAQ:PTHL) and Nexalin Technology (NASDAQ:NXL) are both small-cap medical equipment companies, but which is the better investment? We will contrast the two companies based on the strength of their dividends, institutional ownership, analyst recommendations, valuation, media sentiment, profitability, earnings and risk.

: In the previous week, Pheton had 1 more articles in the media than Nexalin Technology. MarketBeat recorded 1 mentions for Pheton and 0 mentions for Nexalin Technology. Nexalin Technology's average media sentiment score of 0.31 beat Pheton's score of 0.00 indicating that Nexalin Technology is being referred to more favorably in the news media.
Company Overall Sentiment
Pheton Neutral
Nexalin Technology Neutral
: Pheton has a beta of 5.4, suggesting that its share price is 440% more volatile than the S&P 500. Comparatively, Nexalin Technology has a beta of 3.56, suggesting that its share price is 256% more volatile than the S&P 500.
: 0.7% of Nexalin Technology shares are held by institutional investors. 25.3% of Nexalin Technology shares are held by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock is poised for long-term growth.
: Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Pheton
1 Sell rating(s)
0 Hold rating(s)

0 Buy rating(s)

0 Strong Buy rating(s)
1.00
Nexalin Technology
1 Sell rating(s)

0 Hold rating(s)

0 Buy rating(s)

0 Strong Buy rating(s)
1.00
: Pheton has higher revenue and earnings than Nexalin Technology.
Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio
Pheton $305.22K 7.57 -$660K N/A N/A
Nexalin Technology $300K 24.70 -$8.22M -$0.51 N/A
: Pheton has a net margin of 0.00% compared to Nexalin Technology's net margin of -2,722.19%. Pheton's return on equity of 0.00% beat Nexalin Technology's return on equity.
Company Net Margins Return on Equity Return on Assets
Pheton N/A N/A N/A
Nexalin Technology -2,722.19% -195.69% -171.05%

Company	Overall Sentiment
Pheton	Neutral
Nexalin Technology	Neutral

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Pheton	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.00
Nexalin Technology	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.00

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Pheton	$305.22K	7.57	-$660K	N/A	N/A
Nexalin Technology	$300K	24.70	-$8.22M	-$0.51	N/A

Company	Net Margins	Return on Equity	Return on Assets
Pheton	N/A	N/A	N/A
Nexalin Technology	-2,722.19%	-195.69%	-171.05%

Summary

Pheton beats Nexalin Technology on 7 of the 11 factors compared between the two stocks.

How does Pheton compare to enVVeno Medical?

Pheton (NASDAQ:PTHL) and enVVeno Medical (NASDAQ:NVNO) are both small-cap medical companies, but which is the superior investment? We will compare the two businesses based on the strength of their institutional ownership, analyst recommendations, dividends, profitability, media sentiment, earnings, risk and valuation.

: Pheton has a beta of 5.4, suggesting that its share price is 440% more volatile than the S&P 500. Comparatively, enVVeno Medical has a beta of 1.08, suggesting that its share price is 8% more volatile than the S&P 500.
: In the previous week, Pheton had 1 more articles in the media than enVVeno Medical. MarketBeat recorded 1 mentions for Pheton and 0 mentions for enVVeno Medical. Pheton's average media sentiment score of 0.00 equaled enVVeno Medical'saverage media sentiment score.
Company Overall Sentiment
Pheton Neutral
enVVeno Medical Neutral
: Pheton has higher revenue and earnings than enVVeno Medical.
Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio
Pheton $305.22K 7.57 -$660K N/A N/A
enVVeno Medical N/A N/A -$19.47M -$37.89 N/A
: Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Pheton
1 Sell rating(s)
0 Hold rating(s)

0 Buy rating(s)

0 Strong Buy rating(s)
1.00
enVVeno Medical
1 Sell rating(s)

1 Hold rating(s)

0 Buy rating(s)

0 Strong Buy rating(s)
1.50
: 34.7% of enVVeno Medical shares are owned by institutional investors. 15.0% of enVVeno Medical shares are owned by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock will outperform the market over the long term.
: Pheton's return on equity of 0.00% beat enVVeno Medical's return on equity.
Company Net Margins Return on Equity Return on Assets
Pheton N/A N/A N/A
enVVeno Medical N/A -60.88% -56.01%

Company	Overall Sentiment
Pheton	Neutral
enVVeno Medical	Neutral

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Pheton	$305.22K	7.57	-$660K	N/A	N/A
enVVeno Medical	N/A	N/A	-$19.47M	-$37.89	N/A

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Pheton	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.00
enVVeno Medical	1 Sell rating(s)	1 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.50

Company	Net Margins	Return on Equity	Return on Assets
Pheton	N/A	N/A	N/A
enVVeno Medical	N/A	-60.88%	-56.01%

Summary

Pheton beats enVVeno Medical on 6 of the 9 factors compared between the two stocks.

Get Pheton News Delivered to You Automatically

Subscribe Now

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding PTHL and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.

PTHL vs. The Competition

Export

Metric	Pheton	Medical Services Industry	Medical Sector	NASDAQ Exchange
Market Cap	$2.31M	$8.12B	$6.25B	$11.77B
Dividend Yield	N/A	2.19%	2.74%	5.26%
P/E Ratio	N/A	24.84	29.25	27.07
Price / Sales	7.57	17.53	504.68	73.47
Price / Cash	N/A	82.65	43.30	53.90
Price / Book	0.37	4.81	9.67	6.69
Net Income	-$660K	$183.43M	$3.55B	$332.64M
7 Day Performance	-13.33%	0.20%	1.70%	2.01%
1 Month Performance	15.01%	5.27%	5.62%	9.19%
1 Year Performance	-90.66%	0.38%	34.42%	39.59%

Pheton Competitors List

Export

Company	MarketRank	Share Price	Analysts' Price Target	1Y Price Performance	Market Cap	Revenue	P/E Ratio	Employee Count	Indicator(s)
PTHL Pheton	N/A	$0.35 -0.5%	N/A	N/A	$2.31M	$305.22K	N/A	11	Gap Down
PAVM PAVmed	2.1498 of 5 stars	$8.92 -0.2%	$65.00 +628.7%	N/A	$8.88M	$71K	N/A	90	Gap Down
TNON Tenon Medical	0.0581 of 5 stars	$0.76 +0.4%	N/A	N/A	$8.64M	$3.94M	N/A	8	Positive News Upcoming Earnings
SINT Sintx Technologies	3.307 of 5 stars	$1.99 -7.4%	$11.00 +452.8%	N/A	$8.20M	$729K	N/A	40	Positive News Gap Down
NXL Nexalin Technology	0.2534 of 5 stars	$0.35 -6.3%	N/A	N/A	$7.14M	$300K	N/A	3

Related Companies and Tools

Related Companies

Top 10 Stock Comparisons

This page (NASDAQ:PTHL) was last updated on 5/5/2026 by MarketBeat.com Staff.

From Our Partners

Get 30 Days of MarketBeat All Access for Free

Start Your 30-Day Trial

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Pheton (PTHL) Competitors

PTHL vs. PAVM, TNON, SINT, NXL, and NVNO

How does Pheton compare to PAVmed?

Summary

How does Pheton compare to Tenon Medical?

Summary

How does Pheton compare to Sintx Technologies?

Summary

How does Pheton compare to Nexalin Technology?

Summary

How does Pheton compare to enVVeno Medical?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

PTHL vs. The Competition

Pheton Competitors List

Related Companies and Tools

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

Pheton (PTHL) Competitors

PTHL vs. PAVM, TNON, SINT, NXL, and NVNO

How does Pheton compare to PAVmed?

Summary

How does Pheton compare to Tenon Medical?

Summary

How does Pheton compare to Sintx Technologies?

Summary

How does Pheton compare to Nexalin Technology?

Summary

How does Pheton compare to enVVeno Medical?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

PTHL vs. The Competition

Pheton Competitors List

Related Companies and Tools

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools